pentobarbital will decrease the extent or effect of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with powerful CYP3A4 inducers can lead to reduced serum concentrations and loss of antimalarial efficacy pentobarbital will reduce the exten